9
Mar, 2018
CROI 2018 rewards Elena Morrocchi as Italian young researcher at CROI in Boston for her work on HIV specific memory response in early treated Children
9
Mar, 2018
Important information has been issued by ViiV Healthcare in order to highlight recent safety guidelines concerning zidovudine oral solution usage in neonates. Below is the official letter from ViiV Healthcare: The purpose of this letter is to highlight recent safety information regarding zidovudine oraI solution usage in neonates. Zidovudine Oral Solution (ZDV) is indicated for: Human lmmunodeficiency Virus (HIV) infected adults and children in anti-retroviral combination therapy chemoprophylaxis in HIV-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal HIV transmission and for primary prophylaxis of HIV infection […]
9
Mar, 2018
This meeting is the only international European meeting entirely focusing on updates in prevention and treatment of TB in children and adolescents.
27
Feb, 2018
Last November, the Vatican convened a meeting with leaders of major pharmaceutical and medical technology companies, multilateral organizations, donors, governments, organizations providing or supporting services for children living with HIV, and other key stakeholders in order to discuss how to reduce morbidity and mortality among children living with HIV
20
Feb, 2018
We are thrilled to congratulate all the NeoVanc Investigators and Co-Investigators for having reached (and exceeded) the important milestone of 100 children enrolled!
20
Feb, 2018
Antimicrobial resistance (AMR) represents a new focus of research for the PENTA-ID network.
At the end of January 2018, Prof Mike Sharland and two members of the PENTA team (Laura Mangiarini and Davide Bilardi) visited Thai and Vietnamese hospitals potentially interested in participating in a AMR research project
19
Feb, 2018
The second issue of the ZIKA Consortia newsletter is now available in the ZIKAction website. The ZIKAction team is excited to share some of its activities, publications and meetings, in addition to
16
Feb, 2018
We are happy to announce that the enrollment into the CARMA study is moving fast with 31 patients enrolled out of a target of 40 patients.
14
Feb, 2018
Enrollment of patients to the PED-MERMAIDS study is proceeding at a remarkable pace and we have reached 300 patients this month thanks to all sites and their teams.
Specially remarkable the top recruiting site,
13
Feb, 2018
The guidelines provide indications on the prescription of antiretroviral treatment and the management of HIV affected patients. They are addressed to infectious diseases specialists and help provide a reliable benchmark for patients’ associations, policy makers, health organizations and any other subjects involved in this field.